ArticleACS medicinal chemistry letters2020

Selective DYRK1A Inhibitor for the Treatment of Neurodegenerative Diseases: Alzheimer, Parkinson, Huntington, and Down Syndrome.

Robert B KargboPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.